Spreadsheet: 2d91ecd6-4d58-4e04-a593-3c3e3376aa43
Sheet: Sheet1

[NAME] | [NAME] | Patient ID | [NAME] | Array Class | Fibro_const | Cell cycle (SG2M) | Age | E for survival (0=alive, 1= dead) | patient survival (0=NED, 1=AWD, 2=DOD, 3=DOC) | survival months | event for Relapse Free Survival (0=NED, 1=Relapse) | Relapse Free Survival | p53 status (0=wild type, 1=mutation, ND= not determined) | clinical ER (0=ER negative, 1=ER+ via immunohistochemical and/or DC-binding assay >9) | tumor cat=T | node status=N | met=M | grade | histology | reference sample batch ID (four different idenpendently prepared batches were used) | [NAME] # of genes on the microarray | special comments
svcc81 | BC114A-BE | norway 14 | Quiescent | ErbB2+ | low | low | 82 | 1 | 2 | 12 | 1 | 11 | 0 | 1 | 4 | 2 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc123 | BC406A-BE | norway 65 | Quiescent | Normal-like | high | low | 66 | 1 | 2 | 23 | 1 | 0 | 0 | 0 | 4 | 2 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc83 | BC402B-BE | norway 61 | Quiescent | Normal-like | high | low | 58 | 0 | 0 | 57 | 0 | 57 | 0 | 1 | 3 | 0 | 0 | 3 | lobular | CRA | svcc-8k | before sample of chemotherapy pair
svcc124 | BC808A-BE | norway 112 | Quiescent | Normal-like | high | low | 37 | 0 | 0 | 22 | 0 | 22 | 0 | 1 | 3 | 1 | 0 | 1 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc51 | BC309A-BE | norway 57 | Quiescent | ErbB2+ | high | low | 46 | 1 | 2 | 10 | 1 | 0 | 1 | 0 | 4 | 2 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc78 | BC110B-BE | norway 10 | Quiescent | Luminal B | high | low | 58 | 1 | 2 | 30 | 1 | 23 | 0 | 1 | 4 | 0 | 0 | 2 | lobular | CRA | svcc-8k | before sample of chemotherapy pair
svcc84 | BC709B-BE | norway 101 | Quiescent | ErbB2+ | high | low | 73 | 0 | 1 | 33 | 1 | 20 | 1 | 1 | 3 | 2 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc104 | BC708B-BE | norway 100 | Quiescent | Luminal B | high | low | 47 | 1 | 2 | 17 | 1 | 10 | 1 | 1 | 3 | 0 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc93 | BC206A-BE | norway 39 | Quiescent | Luminal B | high | low | 85 | 0 | 0 | 67 | 0 | 67 | 1 | 1 | 3 | 0 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
[NAME] | BC117A-BE | norway 17 | Quiescent | Luminal B | high | low | 76 | 0 | 0 | 80 | 0 | 80 | 0 | 1 | 4 | 0 | 0 | 1 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc53 | BC112B-BE | norway 12 | Quiescent | Luminal B | low | low | 75 | 0 | 3 | 8 | 1 | 7 | 0 | 1 | 3 | 1 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc131 | BC305A-BE | norway 53 | Quiescent | ErbB2+ | low | high | 32 | 1 | 2 | 34 | 1 | 23 | 1 | 1 | 3 | 2 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc120 | BC711B-BE | norway 104 | Quiescent | Normal-like | high | low | 44 | 0 | 0 | 31 | 0 | 31 | 0 | 1 | 3 | 2 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc76 | BC213B-BE | norway 47 | Quiescent | ErbB2+ | low | high | 51 | 0 | 0 | 66 | 0 | 66 | 0 | 1 | 3 | 0 | 0 |  | DCIS | CRA | svcc-8k | before sample of chemotherapy pair
svcc89 | BC123B-BE | norway 26 | Activated | Luminal C | low | high | 72 | 1 | 2 | 43 | 1 | 9 | 1 | 1 | 3 | 0 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc107 | BC208A-BE | norway 41 | Activated | Basal-like | low | high | 49 | 1 | 2 | 9 | 1 | 0 | 1 | 1 | 3 | 1 | 1 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc92 | BC214B-BE | norway 48 | Activated | Luminal C | low | high | 54 | 1 | 2 | 7 | 1 | 4 | 0 | 0 | 3 | 0 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc106 | BC115B-BE | norway 15 | Activated | Luminal C | high | high | 47 | 0 | 0 | 79 | 0 | 79 | 1 | 1 | 3 | 1 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc68 | BC111B-BE | norway 19 | Activated | Luminal C | low | high | 74 | 1 | 2 | 20 | 1 | 0 | 1 | 1 | 4 | 1 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc98 | BC107B-BE | norway 7 | Activated | Luminal C | low | high | 66 | 0 | 1 | 89 | 1 | 39 | 1 | 1 | 3 | 2 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc55 | BC807A-BE | norway 111 | Quiescent | Luminal A | low | high | 55 | 0 | 0 | 30 | 0 | 30 | 0 | 1 | 3 | 0 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc105 | BC805A-BE | norway 109 | Quiescent | Basal-like | high | high | 48 | 0 | 0 | 26 | 0 | 26 | 1 | 0 | 3 | 2 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc108 | BC116A-BE | norway 16 | Activated | Luminal A | high | low | 74 | 0 | 0 | 78 | 0 | 78 | 0 | 1 | 4 | 2 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc122 | BC111A-BE | norway 11 | Activated | Luminal C | high | low | 67 | 1 | 2 | 15 | 1 | 0 | 1 | 1 | 4 | 1 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc101 | BC710A-BE | norway 102 | Activated | Luminal C | high | low | 65 | 0 | 0 | 29 | 0 | 29 | 0 | 1 | 4 | 2 | 0 | 3 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc87 | BC308B-BE | norway 56 | Activated | Luminal A | low | high | 64 | 0 | 0 | 61 | 0 | 61 | 0 | 1 | 3 | 1 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc111 | BC124A-BE | norway 27 | Activated | Luminal A | low | low | 77 | 0 | 1 | 74 | 1 | 59 | 0 | 1 | 3 | 1 | 0 | 1 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svcc134 | BC118B-BE | norway 18 | Activated | Luminal A | low | low | 66 | 0 | 3 | 33 | 0 | 33 | 0 | 1 | 3 | 1 | 0 | 2 | ductal | CRA | svcc-8k | before sample of chemotherapy pair
svl012 | BC104A-BE | norway 4 | Quiescent | Luminal A | low | low | 68 | 0 | 0 | 92 | 0 | 92 | 0 | 1 | 3 | 1 | 0 | 2 | ductal | CRA | svl-8k | before sample of chemotherapy pair
svl006 | BC106B-BE | norway 6 | Quiescent | Luminal A | low | low | 78 | 0 | 3 | 56 | 0 | 56 | 0 | 1 | 3 | 1 | 0 | 1 | papillary | CRA | svl-8k | before sample of chemotherapy pair
svl003 | BC108A-BE | norway 8 | Quiescent | Luminal A | low | low | 47 | 1 | 2 | 22 | 1 | 22 | 0 | 0 | 3 | 1 | 0 | 1 | ductal | CRA | svl-8k | before sample of chemotherapy pair
svl015 | BC119A-BE | norway 21 | Activated | Basal-like | low | high | 79 | 1 | 2 | 14 | 1 | 12 | 0 | 0 | 4 | 2 | 0 | 3 | ductal | CRA | svl-8k | before sample of chemotherapy pair
svl027 | BC120A-BE | norway 22 | Activated | Luminal C | low | high | 43 | 1 | 2 | 34 | 1 | 10 | 1 | 1 | 3 | 1 | 0 | 3 | ductal | CRA | svl-8k | before sample of chemotherapy pair
svl016 | BC121B-BE | norway 24 | Quiescent | Luminal A | high | low | 62 | 1 | 2 | 24 | 1 | 23 | 0 | 1 | 3 | 1 | 0 | 3 | ductal | CRA | svl-8k | before sample of chemotherapy pair
svl018 | BC125A-BE | norway 29 | Quiescent | Luminal A | high | low | 46 | 0 | 0 | 74 | 0 | 74 | 0 | 1 | 3 | 0 | 0 | 2 | lobular | CRA | svl-8k | before sample of chemotherapy pair
shac110 | BC201B-BE | norway 32 | Quiescent | Luminal A | low | low | 55 | 0 | 0 | 73 | 0 | 73 | 0 | 1 | 3 | 2 | 0 | 1 | ductal | CRD | shac-23k | before sample of chemotherapy pair
svl104 | BC205B-AF | norway 37 | Activated | Basal-like | high | high | 71 | 1 | 2 | 22 | 1 | 12 | 1 | 0 | 3 | 1 | 0 | 3 | ductal | CRB | svl-8k | after sample of chemotherapy pair
shac107 | BC210B-AF | norway 43 | Quiescent | Luminal A | high | low | 45 | 0 | 0 | 69 | 0 | 69 | 0 | 1 | 3 | 1 | 0 | 1 | ductal | CRD | shac-23k | after sample of chemotherapy pair
svl020 | BC303B-BE | norway 51 | Quiescent | Luminal C | low | low | 53 | 0 | 0 | 60 | 0 | 60 | 1 | 1 | 3 | 2 | 0 | 3 | ductal | CRA | svl-8k | before sample of chemotherapy pair
svl103 | BC307B-BE | norway 55 | Quiescent | Normal-like | high | low | 71 | 1 | 2 | 16 | 1 | 10 | 1 | 1 | 4 | 1 | 0 | 2 | ductal | CRB | svl-8k | before sample of chemotherapy pair
svl033 | BC404B-BE | norway 63 | Activated | Basal-like | low | high | 44 | 1 | 2 | 41 | 1 | 25 | 1 | 1 | 3 | 0 | 0 | 3 | ductal | CRB | svl-8k | before sample of chemotherapy pair
svl029 | BC405A-BE | norway 64 | Quiescent | Luminal A | low | low | 61 | 0 | 0 | 56 | 0 | 56 | 1 | 1 | 3 | 2 | 0 | 2 | ductal | CRA | svl-8k | before sample of chemotherapy pair
shac091 | BC503B-BE | norway 74 | Quiescent | Luminal A | low | low | 79 | 0 | 3 | 40 | 0 | 40 | 0 | 1 | 3 | 0 | 0 | 1 | mucinous | CRD | shac-23k | before sample of chemotherapy pair
svl031 | BC605B-BE | norway 80 | Activated | Basal-like | high | low | 58 | 1 | 2 | 11 | 1 | 9 | 1 | 0 | 3 | 2 | 0 | 2 | ductal | CRA | svl-8k | before sample of chemotherapy pair
svl026 | BC606B-AF | norway 81 | Activated | Basal-like | low | high | 52 | 1 | 2 | 13 | 1 | 8 | 0 | 1 | 3 | 2 | 0 | 3 | ductal | CRA | svl-8k | after sample of chemotherapy pair
svl036 | BC608B-BE | norway 83 | Quiescent | Luminal A | high | low | 79 | 0 | 1 | 45 | 1 | 0 | 0 | 1 | 4 | 0 | 1 | 2 | ductal | CRA | svl-8k | before sample of chemotherapy pair
shac100 | BC610A-BE | norway 85 | Quiescent | Luminal A | low | low | 79 | 0 | 0 | 39 | 0 | 39 | 0 | 1 | 4 | 1 | 0 | 2 | ductal | CRD | shac-23k | before sample of chemotherapy pair
svl041 | BC702B-BE | norway 90 | Quiescent | Luminal A | high | low | 64 | 0 | 0 | 36 | 0 | 36 | 0 | 1 | 4 | 2 | 0 | 2 | ductal | CRB | svl-8k | before sample of chemotherapy pair
svl035 | BC704B-AF | norway 96 | Quiescent | Luminal A | high | low | 40 | 0 | 0 | 30 | 0 | 30 | 0 | 1 | 3 | 0 | 0 | 1 | lobular | CRB | svl-8k | after sample of chemotherapy pair
svl039 | BC706A-BE | norway 98 | Quiescent | Luminal A | high | low | 57 | 0 | 0 | 32 | 0 | 32 | 1 | 1 | 3 | 1 | 0 | 2 | pleomorph | CRB | svl-8k | before sample of chemotherapy pair
shac092 | BC713A-BE | norway 95 | Activated | Luminal C | low | high | 76 | 0 | 1 | 33 | 1 | 0 | 1 | 1 | 4 | 2 | 0 | 3 | ductal | CRD | shac-23k | before sample of chemotherapy pair